TD Waterhouse Canada’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.7K Hold
1,256
– – ﹤0.01% 1568
2026
Q1
$27.9K Hold
1,256
– – ﹤0.01% 1515
2025
Q4
$29.9K Hold
1,256
– – ﹤0.01% 1308
2025
Q3
$33.5K Hold
1,256
– – ﹤0.01% 1280
2025
Q2
$36.1K Buy
+1,256
New +$33.7K ﹤0.01% 1192
2023
Q2
– Sell
-1,300
Closed -$28K – 1780
2023
Q1
$28K Sell
1,300
-3,000
-70% -$57.4K ﹤0.01% 1038
2022
Q4
$69.2K Hold
4,300
– – ﹤0.01% 836
2022
Q3
$61.1K Hold
4,300
– – ﹤0.01% 868
2022
Q2
$108K Buy
4,300
+3,000
+231% +$89.7K ﹤0.01% 787
2022
Q1
$43.8K Hold
1,300
– – ﹤0.01% 1024
2021
Q4
$42.2K Buy
+1,300
New +$42.8K ﹤0.01% 1032

Other funds holding FMS

TD Waterhouse Canada's FMS Position: Q2 2026 in Review

TD Waterhouse Canada held its Fresenius Medical Care (FMS) position steady in Q2 2026 at 1,256 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

TD Waterhouse Canada first reported a position in FMS in Q4 2021 and has held it in 11 quarters since. The position peaked at $108K in Q2 2022. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • TD Waterhouse Canada held 1,256 shares of Fresenius Medical Care worth $28.7K as of Q2 2026.
  • TD Waterhouse Canada left its Fresenius Medical Care share count unchanged in Q2 2026.
  • Fresenius Medical Care made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1568 holding.
  • TD Waterhouse Canada first reported a position in Fresenius Medical Care in Q4 2021 and has held it in 11 quarters since.
  • TD Waterhouse Canada's Fresenius Medical Care position peaked at $108K in Q2 2022.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.